Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.verified

NWRN.SW

Price:

$7.71

Market Cap:

$163.97M

Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resistant schizophrenia; and Ralfinamide for orphan indication in neuropathic pain. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.[Read more]

Industry

Biotechnology

IPO Date

2006-12-12

Stock Exchange

SIX

Ticker

NWRN.SW

The Enterprise Value as of September 2024 (TTM) for Newron Pharmaceuticals S.p.A. (NWRN.SW) is 206.05M

According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 206.05M. This represents a change of 105.37% compared to the average of 100.33M of the last 4 quarters.

Newron Pharmaceuticals S.p.A. (NWRN.SW) Historical Enterprise Value (quarterly & annually)

How has NWRN.SW Enterprise Value performed in the past?

The mean historical Enterprise Value of Newron Pharmaceuticals S.p.A. over the last ten years is 135.87M. The current 206.05M Enterprise Value has changed 15.07% with respect to the historical average. Over the past ten years (40 quarters), NWRN.SW's Enterprise Value was at its highest in in the June 2015 quarter at 313.75M. The Enterprise Value was at its lowest in in the January 2009 quarter at 0.

Quarterly (TTM)
Annual

Average

135.87M

Median

110.00M

Minimum

45.92M

Maximum

287.23M

Newron Pharmaceuticals S.p.A. (NWRN.SW) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 127.97%

Maximum Annual Enterprise Value = 287.23M

Minimum Annual Increase = -51.00%

Minimum Annual Enterprise Value = 45.92M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023137.18M127.97%
202260.17M31.05%
202145.92M-5.54%
202048.61M-51.00%
201999.20M46.34%
201867.79M-43.88%
2017120.79M-48.23%
2016233.34M-18.76%
2015287.23M11.13%
2014258.47M83.95%

Newron Pharmaceuticals S.p.A. (NWRN.SW) Average Enterprise Value

How has NWRN.SW Enterprise Value performed in the past?

The current Enterprise Value of Newron Pharmaceuticals S.p.A. (NWRN.SW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

81.09M

5-year avg

78.21M

10-year avg

135.87M

Newron Pharmaceuticals S.p.A. (NWRN.SW) Enterprise Value vs. Peers

How is NWRN.SW’s Enterprise Value compared to its peers?

Newron Pharmaceuticals S.p.A.’s Enterprise Value is greater than Santhera Pharmaceuticals Holding AG (108.00M), less than Basilea Pharmaceutica AG (598.13M), greater than Addex Therapeutics Ltd (11.39M), greater than Evolva Holding SA (725.52K), less than Cosmo Pharmaceuticals N.V. (1.27B),

Build a custom stock screener for Newron Pharmaceuticals S.p.A. (NWRN.SW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Newron Pharmaceuticals S.p.A. (NWRN.SW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Newron Pharmaceuticals S.p.A.'s Enterprise Value?

What is the highest Enterprise Value for Newron Pharmaceuticals S.p.A. (NWRN.SW)?

What is the 3-year average Enterprise Value for Newron Pharmaceuticals S.p.A. (NWRN.SW)?

What is the 5-year average Enterprise Value for Newron Pharmaceuticals S.p.A. (NWRN.SW)?

How does the current Enterprise Value for Newron Pharmaceuticals S.p.A. (NWRN.SW) compare to its historical average?